Principles of Cancer Treatment and Anticancer Drug Development

This book explains how current medicines against cancer work and how we find new ones. It provides an easy-to-understand overview of current options to treat patients with cancer, which includes Surgery, Radiation therapy, Chemotherapy, Targeted therapy and Immunotherapy. The efficiency of all these...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Link, Wolfgang (Συγγραφέας, http://id.loc.gov/vocabulary/relators/aut)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04227nam a2200553 4500
001 978-3-030-18722-4
003 DE-He213
005 20191023221938.0
007 cr nn 008mamaa
008 190910s2019 gw | s |||| 0|eng d
020 |a 9783030187224  |9 978-3-030-18722-4 
024 7 |a 10.1007/978-3-030-18722-4  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
100 1 |a Link, Wolfgang.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Principles of Cancer Treatment and Anticancer Drug Development  |h [electronic resource] /  |c by Wolfgang Link. 
250 |a 1st ed. 2019. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2019. 
300 |a XIV, 145 p. 45 illus., 43 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Preface -- Acknowledgements -- Contents -- Abbreviations -- Introduction -- Cancer Therapy -- Cancer drug resistance -- Drug Discovery and Development -- Economic and social implications of modern drug discovery. Index. 
520 |a This book explains how current medicines against cancer work and how we find new ones. It provides an easy-to-understand overview of current options to treat patients with cancer, which includes Surgery, Radiation therapy, Chemotherapy, Targeted therapy and Immunotherapy. The efficiency of all these treatments is limited by the capacity of cancer cells to escape therapy. This book explains the mechanisms of anti-cancer drug resistance and strategies to overcome it. The discovery and development process of a new drug is detailed beginning with the identification and validation of a therapeutic target, the identification of an inhibitor of the target and its subsequent preclinical and clinical development until its approval by regulatory authorities. Particular emphasis has been given to specific aspects of the development process including lead generation and optimization, pharmacokinetics, ADME analysis, pharmacodynamics, toxicity and efficacy assessment, investigational new drug (IND) and new drug application (NDA) and the design of clinical trial and their phases. The book covers many aspects of modern personalized oncology and discusses economic aspects of our current system of developing new medicines and its impact on our societies and on future drug research. The author of this book, Dr. Link counts with more than 20 years of experience in biomedical research reflected in numerous publications, patents and key note and plenary presentations at international conferences. Interested readers, students and teachers should read this book as it provides a unique way to learn/teach about basic concepts in oncology and anti-cancer drug research. 
650 0 |a Cancer research. 
650 0 |a Molecular biology. 
650 0 |a Pharmaceutical technology. 
650 0 |a Biomedical engineering. 
650 0 |a Laboratory medicine. 
650 0 |a Drug resistance. 
650 1 4 |a Cancer Research.  |0 http://scigraph.springernature.com/things/product-market-codes/B11001 
650 2 4 |a Molecular Medicine.  |0 http://scigraph.springernature.com/things/product-market-codes/B1700X 
650 2 4 |a Pharmaceutical Sciences/Technology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21010 
650 2 4 |a Biomedical Engineering/Biotechnology.  |0 http://scigraph.springernature.com/things/product-market-codes/B24000 
650 2 4 |a Laboratory Medicine.  |0 http://scigraph.springernature.com/things/product-market-codes/B15007 
650 2 4 |a Drug Resistance.  |0 http://scigraph.springernature.com/things/product-market-codes/B16020 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783030187217 
776 0 8 |i Printed edition:  |z 9783030187231 
776 0 8 |i Printed edition:  |z 9783030187248 
856 4 0 |u https://doi.org/10.1007/978-3-030-18722-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)